A Clinical Scale to Assess Benzodiazepine Withdrawal
The DOI matches its Crossref record.
Abstract
The objective, sensitive, and reliable quantitation of withdrawal symptoms is essential to assess physical dependence on drugs. Data collected from 23 patients abusing high doses of benzodiazepines (mean diazepam dose equivalents, 150 mg/day; range, 40–500) and from 40 long-term therapeutic users randomized to receive either placebo (N = 19) or diazepam (N = 21; mean diazepam dose equivalents, 15 mg/day; range, 5–40; mean duration of use, 72 months; range, 6–240) were analyzed. Information on the type and severity of symptoms was obtained from several assessment instruments. In the high-dose abuse group, plasma benzodiazepine concentrations were measured daily and the 3 consecutive days of greatest relative daily fall were considered the critical withdrawal period. Selection of the 22 items of the Clinical Institute Withdrawal Assessment-Benzodiazepines (CIWA-B) was based on statistically significant differences between baseline and critical withdrawal periods in high-dose subjects and between symptoms associated with placebo and diazepam in low-dose subjects, using contingency tables and logistic regression analysis. Of the 104 symptoms measured by the assessment instruments, 22 symptoms were found to distinguish withdrawal from prewithdrawal. These symptoms were selected based on significant differences (t-test, p ranged between <0.05 and <0.001) on type and severity of symptoms between baseline and the clinical withdrawal period in high-dose subjects, and on differences (cH2: P ranged between <0.05 and <0.001) in type of symptoms in placebo and diazepam subjects during the first week of withdrawal among the longterm therapeutic users of benzodiazepines. From these 22 symptoms, we constructed the CIWA-B, a scale of 20 five-point items and two additional values. We propose the CIWA-B as an instrument to assess and monitor benzodiazepine-like withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Scales designed for monitoring BZD withdrawal symptoms exist, including the Clinical Institute Withdrawal Assessment Scale-Benzodiazepines (CIWA-B)119 and the BZD Withdrawal Symptom Questionnaire (BWSQ).120”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [119]
Citations
Cites
Still being checked.
Cited by
Morin, C. M., Bastien, C., Guay, B., Radouco-Thomas, M., Leblanc, J., & Vallières, A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.332 · Cited by 348
Boone, M., Brown, N. J., MOON, M. A., Schuman, D. J., Thomas, J. S., & Wright, D. (2004) · Cited by 319
Withdrawing Benzodiazepines in Primary Care
Lader, M., Tylee, A., & Donoghue, J. (2009) · CNS Drugs · doi:10.2165/0023210-200923010-00002 · Cited by 318
“[43-50] Many ed as a ‘pure’ antagonist, subsequent work in both other studies were excluded for a variety of reasons, animals and humans has suggested that flumazenil is including inappropriate outcome measures, setting a mixed agonist/antagonist, depending partly on and selection of participants.[51-73] Several of th…”
ResultCammarano, W. B., Pittet, J.-F., Weitz, S., Schlobohm, R. M., & Marks, J. D. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00015 · Cited by 290
Gosselin, P., Ladouceur, R., Morin, C. M., Dugas, M. J., & Baillargeon, L. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.5.908 · Cited by 122
Metadata
- Authors
- BUSTO, U. E., SYKORA, K., & SELLERS, E. M.
- Affiliations
- University of Toronto (CA)
- ORCID
- SELLERS, EDWARD M.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 1989-12
- Volume
- 9
- Issue
- 6
- Pages
- 412???416
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1990397462
- Cited by
- 125
- References
- 0
- Citations by year
- 2026: 13 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 9 · 2021: 7 · 2020: 8 · 2019: 4 · 2018: 3 · 2016: 4 · 2015: 2 · 2014: 6 · 2013: 1 · 2012: 4
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- benzodiazepine withdrawal, benzodiazepine dependence, diazepam, withdrawal time, scale development
- MeSH terms
- Adult, Arousal, Benzodiazepines, Dose-Response Relationship, Drug, Humans, Long-Term Care, Middle Aged, Psychiatric Status Rating Scales, Psychometrics, Retrospective Studies, Sleep Stages, Substance Withdrawal Syndrome, Anti-Anxiety Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Clinical Scale to Assess Benzodiazepine Withdrawal. https://app.cochat.ai/papers/10.1097/00004714-198912000-00005
- The paper
- BUSTO, U. E., SYKORA, K., & SELLERS, E. M. (1989). A Clinical Scale to Assess Benzodiazepine Withdrawal. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-198912000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.